Cargando…
Examining patient and professional perspectives in the UK for gene therapy in haemophilia
INTRODUCTION: With the development of gene therapy for people with haemophilia (PWH), it is important to understand how people impacted by haemophilia (PIH) and clinicians prioritise haemophilia treatment attributes to support informed treatment decisions. OBJECTIVE: To examine the treatment attribu...
Autores principales: | Woollacott, Ione, Morgan, George, Chowdary, Pratima, O'Hara, Jamie, Franks, Bethany, van Overbeeke, Eline, Dunn, Nicola, Michelsen, Sissel, Huys, Isabelle, Martin, Antony, Cawson, Matthew, Brownrigg, Jack, Winburn, Ian, Thomson, Jim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546085/ https://www.ncbi.nlm.nih.gov/pubmed/35438818 http://dx.doi.org/10.1111/hae.14572 |
Ejemplares similares
-
Patient perspectives regarding gene therapy in haemophilia: Interviews from the PAVING study
por: van Overbeeke, Eline, et al.
Publicado: (2020) -
Patient preferences for gene therapy in haemophilia: Results from the PAVING threshold technique survey
por: van Overbeeke, Eline, et al.
Publicado: (2021) -
Patient Preferences to Assess Value IN Gene Therapies: Protocol Development for the PAVING Study in Hemophilia
por: van Overbeeke, Eline, et al.
Publicado: (2021) -
Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab
por: Chowdary, Pratima
Publicado: (2018) -
Expert opinion on the UK standard of care for haemophilia patients with inhibitors: a modified Delphi consensus study
por: Khair, Kate, et al.
Publicado: (2021)